- Home
- / NattoPharma
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
NattoPharma financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Revenue
KR214.5 M
FY, 2020
CreditSafe Score
?
Score changed on Jun 07, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| NOK | FY, 2018 | FY, 2019 | FY, 2020 |
|---|---|---|---|
| Revenue | 101.7M | 127.1M | 214.5M |
| Cost of goods sold | 58.0M | 76.2M | 123.1M |
| Gross profit | 49.1M | 54.9M | 94.8M |
| Gross profit margin, % | 48.3% | 43.2% | 44.2% |
| Operating expense total | 44.2M | 47.4M | 61.9M |
| Depreciation and amortization | 7.3M | 7.9M | 11.4M |
| EBITDA | 4.9M | (8.5M) | 54.6M |
| EBITDA margin, % | 4.8% | -6.7% | 25.5% |
| EBIT | (2.4M) | (16.5M) | 43.3M |
| EBIT margin, % | -2.3% | -12.9% | 20.2% |
| Interest income | 2.8M | 2.7M | 1.4M |
| Interest expense | 335.0K | 924.0K | 1.1M |
| Pre tax profit | 1.0M | (14.1M) | 44.1M |
| Income tax expense | (630.0K) | (435.0K) | (24.5M) |
| Net Income | 1.7M | (13.7M) | 68.6M |